Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer

Japanese Journal of Clinical Oncology

Volumn 35, Issue 1, 2005, Pages 6-12

  Choi, In Sill ^a   Oh, Do Youn ^a   Kwon, Jung Hye ^a   Kim, Sang Il ^a   Park, Sook Ryun ^a   Bak, Ji Youn ^a   Kim, Jee Hyun ^a   Kim, Dong Wan ^a   Kim, Young Tae ^a   Kim, Tae You ^a   You, Chul Kyu ^a   Kim, Young Whan ^a   Heo, Dae Seog ^a   Bang, Yung Jue ^a   Sung, Sook Whan ^a   Park, Chan Il ^a   Kim, Noe Kyeong ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Neoadjuvant chemotherapy; Non small cell lung cancer; Paclitaxel; Platinum

Indexed keywords

ANTIEMETIC AGENT; CARBOPLATIN; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; PACLITAXEL; PLATINUM DERIVATIVE; ANTINEOPLASTIC AGENT; PLATINUM;

ADULT; AGED; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; FLUSHING; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MORTALITY; MYALGIA; NAUSEA; NEUROTOXICITY; PERIOPERATIVE PERIOD; PERIPHERAL NEUROPATHY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; SKIN MANIFESTATION; THORAX DISEASE; THROMBOCYTOPENIA; ADJUVANT CHEMOTHERAPY; DISEASE COURSE; DRUG ADMINISTRATION; LUNG RESECTION; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PERIOPERATIVE CARE; PLATINUM; PNEUMONECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 14944386981     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyi008     Document Type: Article

References (29)

1. Mountain CF. Revisions in the International System for Staging Cancer. Chest 1997;111:1710-7.
2. Shields TW. The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell lung carcinoma of the lung: a commentary. J Thorac Cardiovasc Surg 1990;99:48-53.
3. Martini N, Kris MG, Flehinger BJ, et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993;55:1365-73.
4. Pujol JL, Hayot M, Rouanet P, et al. Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small cell lung cancer. Chest 1994;106:1451-5.
5. Elias AD, Skarin AT, Leong T, et al. Neoadjuvant therapy for surgically staged N2 non-small cell lung caner (NSCLC). Lung Cancer 1997;17:147-61.
6. Rosell R, Gomez-Codian J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994;330:153-8.
7. Roth JA, Fossella F, Komaki R, et al. A randomized tiral comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994;86:673-80.
8. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992;53:992-8.
9. Depierre A, Westeel V, Jacoulet P, et al. Preoperative chemotherapy for non-small cell lung cancer. Cancer Treat Rev 2001;27:119-27.
10. Van Zandwijk N, Smit EF, Kramer GWP, et al. Gemcitabine and cisplatin as induction regimen for patient with biopsy-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 2000;18:2658-64.
11. Migliorino MR, De Marinis F, Nelli F, et al. A 3-week schedule of gemcitabine and cisplatin as induction chemotherapy for stage III non-small cell lung cancer. Lung Cancer 2002;35:319-27.
12. Pisters KM, Ginsberg RJ, Giroux DJ, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality Lung Oncology Team (BLOT). J Thorac Cardiovasc Surg 2000;119: 429-39.
13. Betticher DC, Schmitz S-FH, Totsch M, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003;21:1752-9.
14. O'Brien MER, Splinter T, Smit EF, et al. Carboplatin and paclitaxel (taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958). Eur J Cancer 2003;39:1416-22.
15. De Marinis F, Nelli F, Migliorino MR, et al. Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven stage IIIA (N2) non-small cell lung cancer. Cancer 2003;98:1707-15.
16. Bonomi P, Kim KM, Fairclough D, et al. Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group Trial. J Clin Oncol 2000;18:623-31.
17. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 2002;346:92-8.
18. Belani CP, Natale PB, Lee JS. Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1998;17:455a (abstract 1751).
19. Kelly K, Crowley J, Bunn PA. A randomized phase III trial of paclitaxel plus carboplatin (PC) versus vinorelbine plus cisplatin (VC) in untreated non-small cell lung cancer (NSCLC): South West Oncology Group (SWOG) trial. J Clin Oncol 2001;19:3210-8.
20. Miller AB, Hoodgstraten B, Staquet M. Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
22. Lynch TJ. Treatment of Stage III Non-small Cell Lung Cancer. ASCO Educational Book, Spring, 1998;265-75.
23. Choi IS, Kim BS, Heo DS, et al. Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer. Lung Cancer 2003;39:99-101.
24. Siegenthaler MP, Pisters KM, Merriman KW, et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 2001;71:1105-12.
25. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer; a review of the current evidence. Chest 2003;123: 137S-46S.
26. Baron RL, Levitt RG, Sagel SS, et al. Computed tomography in the preoperative evaluation of bronchogenic carcinoma. Radiology 1982;145:727-32.
27. Daly BDT Jr, Faling LJ, Bite G, et al. Mediastinal lymph node evaluation by computed tomography in lung cancer. J Thorac Cardiovasc Surg 1987;94:664-72.
28. Staples CA, Muller NL, Miller RR, et al. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988;167:367-72,
29. Sung SW, Kim YT, Kim DS, et al. Evaluation of lymph node staging of chest CT in non-small cell lung cancer. Kor J Thorac Cardiovasc Surg 1998;31:271-8.